United StatesThe United States viscosupplementation market, driven by a high prevalence of knee osteoarthritis, advanced healthcare systems, and extensive R&D activities. Favorable reimbursement policies and growing patient preference for minimally invasive treatments further boost market growth.
GermanyGermany is a key market in Europe for viscosupplementation, supported by its strong...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian